Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new mutation in the XEDAR gene might cause a rare skin condition called hypohidrotic ectodermal dysplasia.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Telocytes in the scalp may help with skin regeneration and maintenance.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Leflunomide and anthralin may effectively treat severe alopecia areata.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Microneedling combined with skinbooster effectively treats striae rubrae, with confocal microscopy confirming collagen changes.

Some minoxidil combinations can help differentiate leukemia cells without harming other cells.

Apoptosis may contribute to hair loss in androgenetic alopecia.

Interleukin-6 may play a role in causing alopecia areata.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Terbinafine can cause hair loss.